Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Over the past few years, Kansas-based family physician Josh Umbehr, MD, has sent dozens of emails to Amazon's CEO Jeff Bezos, urging him to direct the company toward the prescription drug market, reports CNBC.
The Food and Drug Administration on Tuesday approved a new use for Botox treatment.
Takeda Pharmaceutical Co. on Tuesday earned Food and Drug Administration approval for a new dosage of its cancer drug Alunbrig.
Phoenix Children's Hospital, with the help of three of its native-born Puerto Rican physicians, donated more than $20,000 worth of medical supplies to Hurricane Maria victims Oct. 3.
The FDA will step up efforts to deal with the skyrocketing cost of prescription medicine by encouraging development of "complex" generic drugs, wrote FDA Commissioner Scott Gottlieb, MD, in an Oct. 2 blog post.
The FDA launched a more accessible dashboard for its adverse event reporting system, the database that contains medication errors and product quality complaints, the agency said Sept. 28.
A U.S. District Court judge denied the generic drug industry trade group's request for a preliminary injunction of Maryland's law that penalizes drugmakers for price gouging —allowing the state law to take effect, according to Reuters.
Hundreds of people lined up outside of Las Vegas blood banks in the hours after a gunman opened fire on the Vegas strip, killing at least 50 people and injuring more than 400, reports The Hill.
An oncology drug trial halted after a patient death most captured the attention of readers in September.
Here are five drug and medical device companies that made headlines in the past week.